Morgan Stanley (MS) is back in focus after filing amended S-1s for proposed spot Ethereum and Solana ETFs with industry-low 0.14% fees, alongside recent Bitcoin accumulation and a registered Bitcoin ETF.

That crypto ETF push comes after a strong run in Morgan Stanley’s stock, with a 90 day share price return of 35.81% and a 1 year total shareholder return of 72.22%. This suggests momentum has been building as earnings expectations and funding activity, including recent fixed income offerings, keep the company in the spotlight.

If you are looking beyond Morgan Stanley’s crypto and capital markets activity, this could be a useful moment to broaden your search and check out 19 cryptocurrency and blockchain stocks

After a 72.22% 1 year total return and a recent price of US$223.17 that sits above some intrinsic value estimates, it is fair to ask whether Morgan Stanley is now stretched, or if investors still see upside that markets are already pricing in.

Most Popular Narrative: 17.3% Overvalued

At a last close of $223.17 versus a most followed fair value estimate of about $190.33, the current Morgan Stanley share price sits well above that narrative anchor, which rests on a detailed set of earnings and valuation assumptions.

The analysts have a consensus price target of $190.33 for Morgan Stanley based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $221.0, and the most bearish reporting a price target of just $153.0.

Curious what kind of earnings path and profit margins underpin that fair value gap for Morgan Stanley? The narrative leans on measured revenue growth, gradually improving profitability and a future earnings multiple that differs from where the stock trades today. The full breakdown spells out exactly how those moving parts combine into a single fair value number.

Result: Fair Value of $190.33 (OVERVALUED)

However, there are still clear risks to that analyst narrative, including pressure from low-fee passive products and potential regulatory shifts that could lift Morgan Stanley's costs.

Another View On Morgan Stanley Using Market Multiples

Analysts see Morgan Stanley as about 17.3% above their fair value estimate, yet on a simple P/E basis the picture is different. At 20.1x earnings, MS trades well below the US Capital Markets industry at 40.6x and below its peer average of 32.5x, but slightly above a fair ratio of 19x. That mix of discount to peers and premium to the fair ratio raises a practical question for investors: is the bigger risk now overpaying, or being too cautious on a stock the market already rewards less than its sector?

Next Steps

Reading this mix of optimism and concern around Morgan Stanley, it makes sense to move fast and weigh the risks against the rewards for yourself. To see the full balance of both sides, review the 3 key rewards and 3 important warning signs

Looking for more investment ideas beyond Morgan Stanley?

If Morgan Stanley has sharpened your interest in financial opportunities, do not stop here. Broaden your watchlist now so you are not late to the next setup.

• Target potential mispricings by scanning for quality companies trading below their estimated worth through the 45 high quality undervalued stocks
• Strengthen your income stream by reviewing companies with robust payouts using the 8 dividend fortresses
• Prioritise resilience by focusing on businesses with healthier finances via the solid balance sheet and fundamentals stocks screener (48 results)

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.